248 related articles for article (PubMed ID: 30794469)
21. Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab.
Gisondi P; Lora V; Bonauguri C; Russo A; Lippi G; Girolomoni G
Br J Dermatol; 2013 Apr; 168(4):749-55. PubMed ID: 23110708
[TBL] [Abstract][Full Text] [Related]
22. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
23. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R
J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.
Carpentieri A; Pacello L; De Marco IM; Loiacono A; Picconi O; Loconsole F
J Dermatolog Treat; 2016 Oct; 27(5):399-405. PubMed ID: 26822691
[TBL] [Abstract][Full Text] [Related]
26. Considerations for Systemic Treatment of Psoriasis in Obese Patients.
Gisondi P; Del Giglio M; Girolomoni G
Am J Clin Dermatol; 2016 Dec; 17(6):609-615. PubMed ID: 27411805
[TBL] [Abstract][Full Text] [Related]
27. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
Menter A; Korman NJ; Elmets CA; Feldman SR; Gelfand JM; Gordon KB; Gottlieb AB; Koo JY; Lebwohl M; Lim HW; Van Voorhees AS; Beutner KR; Bhushan R
J Am Acad Dermatol; 2009 Sep; 61(3):451-85. PubMed ID: 19493586
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
[TBL] [Abstract][Full Text] [Related]
29. Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Wilsmann-Theis D; Frambach Y; Philipp S; Weyergraf AJ; Jacobi A; Mössner R; Gerdes S
Dermatology; 2015; 230(2):119-27. PubMed ID: 25661583
[TBL] [Abstract][Full Text] [Related]
30. Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
[TBL] [Abstract][Full Text] [Related]
31. Compounds of psoriasis with obesity and overweight.
Owczarczyk-Saczonek A; Placek W
Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):761-772. PubMed ID: 28894050
[TBL] [Abstract][Full Text] [Related]
32. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Kim NN; Lio PA; Morgan GA; Jarvis JN; Pachman LM
Arch Dermatol; 2011 Jul; 147(7):831-5. PubMed ID: 21422326
[TBL] [Abstract][Full Text] [Related]
33. Interventions for nail psoriasis.
de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
[TBL] [Abstract][Full Text] [Related]
34. Comparative tolerability of systemic treatments for plaque-type psoriasis.
McClure SL; Valentine J; Gordon KB
Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
[TBL] [Abstract][Full Text] [Related]
35. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
36. Treatment of psoriasis: focus on clinic-based management with infliximab.
de Eusebio E; Armario-Hita JC; de Miquel VA
Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S5-16. PubMed ID: 24777571
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D and systemic therapy.
van de Kerkhof P
Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognosis in patients with psoriasis.
Gulliver W
Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
[TBL] [Abstract][Full Text] [Related]
39. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
Bonifati C; Lora V; Graceffa D; Nosotti L
World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
[TBL] [Abstract][Full Text] [Related]
40. How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Burden-Teh E; Lam ML; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Helbling I; Murphy R
Br J Dermatol; 2015 Aug; 173(2):614-8. PubMed ID: 25601323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
